"Mastocytosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogenous group of disorders characterized by the abnormal increase of MAST CELLS in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).
Descriptor ID |
D008415
|
MeSH Number(s) |
C04.557.450.565.465 C17.800.508 C20.543.520.350
|
Concept/Terms |
Mastocytosis- Mastocytosis
- Mastocytoses
- Mast Cell Activation Syndrome
- Mast Cell Activation Disease
- Mast Cell Activation Syndromes
- Mast Cell Disease
- Mast Cell Diseases
- Mast-Cell Disease
- Mast-Cell Diseases
|
Below are MeSH descriptors whose meaning is more general than "Mastocytosis".
Below are MeSH descriptors whose meaning is more specific than "Mastocytosis".
This graph shows the total number of publications written about "Mastocytosis" by people in this website by year, and whether "Mastocytosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 3 | 2 | 5 |
2018 | 6 | 2 | 8 |
2019 | 3 | 0 | 3 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mastocytosis" by people in Profiles.
-
Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome. J Allergy Clin Immunol Pract. 2021 08; 9(8):3198-3199.
-
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM). J Allergy Clin Immunol Pract. 2021 06; 9(6):2139-2144.
-
Unmasked: an insight into three patients' rare disease experiences during the COVID-19 pandemic. Orphanet J Rare Dis. 2021 02 26; 16(1):88.
-
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms. J Allergy Clin Immunol Pract. 2021 05; 9(5):2083-2086.
-
Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders? J Investig Allergol Clin Immunol. 2021 Apr 20; 31(2):193-195.
-
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020 Nov; 100:327-332.
-
COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome? J Biol Regul Homeost Agents. 2020 Sep-Oct,; 34(5):1633-1636.
-
Neuroinflammatory disorders and mastocytosis: A possible association? J Allergy Clin Immunol Pract. 2019 Nov - Dec; 7(8):2878-2881.e1.
-
Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2387-2395.e3.
-
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome. J Allergy Clin Immunol Pract. 2019 04; 7(4):1125-1133.e1.